Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer

World Journal of Gastroenterology

Volumn 14, Issue 42, 2008, Pages 6453-6457

  Fotiadis, Constantine Iosif ^a,b   Stoidis, Christos Nikolaou ^a   Spyropoulos, Basileios Georgiou ^a   Zografos, Eleftherios Dimitriou ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b University Hospital Attikon   (Greece)

Author keywords

Colorectal cancer; Prebiotics; Prevention; Probiotics; Synbiotics; Treatment

Indexed keywords

BETA GLUCURONIDASE; BUTYRIC ACID; FRUCTOSE OLIGOSACCHARIDE; GAMMA INTERFERON; GLUTATHIONE TRANSFERASE; INTERLEUKIN 1BETA; INULIN; PREBIOTIC AGENT; PROBIOTIC AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE; SYNBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; BACTERIAL GROWTH; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM INFANTIS; BUTYRIVIBRIO FIBRISOLVENS; CANCER INHIBITION; CANCER PREVENTION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLORECTAL CANCER; CYTOKINE PRODUCTION; DRUG EFFICACY; HUMAN; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; NONHUMAN; REVIEW; TUMOR IMMUNITY; ANIMAL; COLORECTAL TUMOR; DIET SUPPLEMENTATION; TREATMENT OUTCOME;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENTS; HUMANS; PROBIOTICS; TREATMENT OUTCOME;

EID: 63449101491     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.6453     Document Type: Review

References (50)

1. Goldberg RM. Advances in the treatment of metastatic colorectal cancer. Oncologist 2005; 10 Suppl 3: 40-48
2. Huycke MM, Gaskins HR. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med (Maywood) 2004; 229: 586-597
3. Rafter J. The effects of probiotics on colon cancer development. Nutr Res Reviews 2004; 17: 277-284
4. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989; 66: 365-378
5. Guarner F, Schaafsma GJ. Probiotics. Int J Food Microbiol 1998; 39: 237-238
6. Fuller R. Probiotics in human medicine. Gut 1991; 32: 439-442
7. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125: 1401-1412
8. Shahani KM, Ayebo AD. Role of dietary lactobacilli in gastrointestinal microecology. Am J Clin Nutr 1980; 33: 2448-2457
9. Kampman E, Goldbohm RA, van den Brandt PA, van't Veer P. Fermented dairy products, calcium, and colorectal cancer in The Netherlands Cohort Study. Cancer Res 1994; 54: 3186-3190
10. Goldin BR, Gorbach SL. Alterations of the intestinal microflora by diet, oral antibiotics, and Lactobacillus: decreased production of free amines from aromatic nitro compounds, azo dyes, and glucuronides. J Natl Cancer Inst 1984; 73: 689-695
11. Goldin BR, Gorbach SL. The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity. Am J Clin Nutr 1984; 39: 756-761
12. Goossens D, Jonkers D, Russel M, Stobberingh E, Van Den Bogaard A, StockbrUgger R. The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: a placebo-controlled study on the onset and duration of effects. Aliment Pharmacol Ther 2003; 18: 495-505
13. Tannock GW, Munro K, Harmsen HJ, Welling GW, Smart J, Gopal PK. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol 2000; 66: 2578-2588
14. Marteau P, Pochart P, Flourie B, Pellier P, Santos L, Desjeux JF, Rambaud JC. Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans. Am J Clin Nutr 1990; 52: 685-688
15. Goldin BR, Swenson L, Dwyer J, Sexton M, Gorbach SL. Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. J Natl Cancer Inst 1980; 64: 255-261
16. Spanhaak S, Havenaar R, Schaafsma G. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr 1998; 52: 899-907
17. Modler GW, McKellar RC, Yaguchi M. Bifidobacteria and bifidogenic factors. J Inst Can Sci Technol Ailment 1990; 23: 29-41
18. Rowland IR, Rumney CJ, Coutts JT, Lievense LC. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 1998; 19: 281-285
19. Abdelali H, Cassand P, Soussotte V, Daubeze M, Bouley C, Narbonne JF. Effect of dairy products on initiation of precursor lesions of colon cancer in rats. Nutr Cancer 1995; 24: 121-132.
20. Bruce WR. Recent hypotheses for the origin of colon cancer. Cancer Res 1987; 47: 4237-4242
21. Lidbeck A, Geltner-Allinger U, Orrhage KM, Ottova L, Brismar B, Gustafson J, Rafter JJ, Nord CE. Impact of L.acidophilus supplements on the faecal microflora and soluble faecal bile acids in colon cancer patients. Microb Ecology in Health and Disease 1991; 4: 81-88
22. Biasco G, Paganelli GM, Brandi G, Brillanti S, Lami F, Callegari C, Gizzi G. Effect of lactobacillus acidophilus and bifidobacterium bifidum on rectal cell kinetics and fecal pH. Ital J Gastroenterol 1991; 23: 142
23. Morotomi M, Mutai M. In vitro binding of potent mutagenic pyrolysates to intestinal bacteria. J Natl Cancer Inst 1986; 77: 195-201
24. Orrhage KM, Annas A, Nord CE, Brittebo EB, Rafter JJ. Effects of lactic acid bacteria on the uptake and distribution of the food mutagen Trp-P-2 in mice. Scand J Gastroenterol 2002; 37: 215-221
25. Hayatsu H, Hayatsu T. Suppressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human. Cancer Lett 1993; 73: 173-179
26. Rowland IR, Grasso P. Degradation of N-nitrosamines by intestinal bacteria. Appl Microbiol 1975; 29: 7-12
27. Pool-Zobel BL. Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data. Br J Nutr 2005; 93 Suppl 1: S73-S90
28. Sengupta S, Muir JG, Gibson PR. Does butyrate protect from colorectal cancer? J Gastroenterol Hepatol 2006; 21: 209-218
29. Wong CS, Sengupta S, Tjandra JJ, Gibson PR. The influence of specific luminar factors on the colonic epithelium: high-dose butyrate and physical changes suppress early carcinogenesis events in rats. Dis Colon Rectum 2005; 48: 549-559
30. Ohkawara S, Furuya H, Nagashima K, Asanuma N, Hino T. Oral administration of butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of mice. J Nutr 2005; 135: 2878-2883
31. Jan G, Belzacq AS, Haouzi D, Rouault A, Metivier D, Kroemer G, Brenner C. Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ 2002; 9: 179-88
32. Geier MS, Butler RN, Howarth GS. Probiotics, prebiotics and synbiotics: a role in chemoprevention for colorectal cancer? Cancer Biol Ther 2006; 5: 1265-1269
33. Reddy GV, Friend BA, Shahani KM, Farmer RE. Antitumour activity of yogurt components. J Food Prot 1983; 46: 8-11
34. Baricault L, Denariaz G, Houri JJ, Bouley C, Sapin C, Trugnan G. Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation. Carcinogenesis 1995; 16: 245-252
35. Biffi A, Coradini D, Larsen R, Riva L, Di Fronzo G. Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr Cancer 1997; 28: 93-99
36. Sekine K, Toida T, Saito M, Kuboyama M, Kawashima T, Hashimoto Y. A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice. Cancer Res 1985; 45: 1300-1307
37. Matsuzaki T. Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int J Food Microbiol 1998; 41: 133-140
38. Lee JW, Shin JG, Kim EH, Kang HE, Yim IB, Kim JY, Joo HG, Woo HJ. Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. J Vet Sci 2004; 5: 41-48
39. Sun J, Shi YH, Le GW, Ma XY. Distinct immune response induced by peptidoglycan derived from Lactobacillus sp. World J Gastroenterol 2005; 11: 6330-6337
40. Ghoneum M, Hamilton J, Brown J, Gollapudi S. Human squamous cell carcinoma of the tongue and colon undergoes apoptosis upon phagocytosis of Saccharomyces cerevisiae, the baker's yeast, in vitro. Anticancer Res 2005; 25: 981-989
41. Ghoneum M, Gollapudi S. Induction of apoptosis in breast cancer cells by Saccharomyces cerevisiae, the baker's yeast, in vitro. Anticancer Res 2004; 24: 1455-1463
42. Pool-Zobel BL, Neudecker C, Domizlaff I, Ji S, Schillinger U, Rumney C, Moretti M, Vilarini I, Scassellati-Sforzolini R, Rowland I. Lactobacillus- and bifidobacterium-mediated antigenotoxicity in the colon of rats. Nutr Cancer 1996; 26: 365-380
43. Challa A, Rao DR, Chawan CB, Shackelford L. Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis 1997; 18: 517-521
44. Friedenreich CM, Brant RF, Riboli E. Influence of methodologic factors in a pooled analysis of 13 case-control studies of colorectal cancer and dietary fiber. Epidemiology 1994; 5: 66-79
45. Hughes R, Rowland IR. Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon. Carcinogenesis 2001; 22: 43-47
46. Bauer-Marinovic M, Florian S, Muller-Schmehl K, Glatt H, Jacobasch G. Dietary resistant starch type 3 prevents tumor induction by 1,2-dimethylhydrazine and alters proliferation, apoptosis and dedifferentiation in rat colon. Carcinogenesis 2006; 27: 1849-1859
47. Ghoneum M, Abedi S. Enhancement of natural killer cell activity of aged mice by modified arabinoxylan rice bran (MGN-3/Biobran). J Pharm Pharmacol 2004; 56: 1581-1588
48. Rowland IR, Rumney CJ, Coutts JT, Lievense LC. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 1998; 19: 281-285
49. Le Leu RK, Brown IL, Hu Y, Bird AR, Jackson M, Esterman A, Young GP. A synbiotic combination of resistant starch and Bifidobacterium lactis facilitates apoptotic deletion of carcinogen-damaged cells in rat colon. J Nutr 2005; 135: 996-1001
50. Roller M, Pietro Femia A, Caderni G, Rechkemmer G, Watzl B. Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis. Br J Nutr 2004; 92: 931-938